Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response

Biomaterials

Volumn 28, Issue 35, 2007, Pages 5344-5357

  Kanchan, Vibhu ^a   Panda, Amulya K ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Cellular interaction; Immune response; Macrophage; Microparticles; Nanoparticles; Polylactide

Indexed keywords

ANTIBODIES; ANTIGENS; MACROPHAGES; MOLECULAR INTERACTIONS; NANOPARTICLES;

CELLULAR INTERACTION; IMMUNE RESPONSE; MICROPARTICLES; POLYLACTIDE; POLYMER PARTICLE DELIVERY SYSTEMS;

BIOPOLYMERS;

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOPARTICLE; POLYLACTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; HEPATITIS B SURFACE ANTIGENS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PARTICLE SIZE; POLYESTERS; RATS; RATS, WISTAR; VIRAL HEPATITIS VACCINES;

EID: 34948832042     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.08.015     Document Type: Article

References (48)

1. Cleland J.L. Single-administration vaccines: controlled-release technology to mimic repeated immunizations. Trends Biotechnol 17 (1999) 25-29
2. Jiang W., Gupta R.K., Deshpande M.C., and Schwendeman S.P. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57 (2005) 391-410
3. O'Hagan D.T., and Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2 (2003) 269-283
4. Men Y., Audran R., Thomasin C., Eberl G., Demotz S., Merkle H.P., et al. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 17 (1999) 1047-1056
5. Carcaboso A.M., Hernandez R.M., Igartua M., Rosas J.E., Patarroyo M.E., and Pedraz J.L. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Vaccine 22 (2004) 1423-1432
6. Tabata Y., and Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of l-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res 22 (1988) 837-858
7. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., and Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol Immunol 28 (1991) 287-294
8. Thiele L., Rothen-Rutishauser B., Jilek S., Wunderli-Allenspach H., Merkle H.P., and Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J Control Release 76 (2001) 59-71
9. Hilbert A.K., Fritzsche U., and Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine 17 (1999) 1065-1073
10. Tabata Y., Inoue Y., and Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 14 (1996) 1677-1685
11. Shi L., Caulfield M.J., Chern R.T., Wilson R.A., Sanyal G., and Volkin D.B. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 91 (2002) 1019-1035
12. Gutierro I., Hernandez R.M., Igartua M., Gascon A.R., and Pedraz J.L. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21 (2002) 67-77
13. Harding C.V., and Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 153 (1994) 4925-4933
14. Chong C.S., Cao M., Wong W.W., Fischer K.P., Addison W.R., Kwon G.S., et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release 102 (2005) 85-99
15. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377 (2004) 159-169
16. Shen Z., Reznikoff G., Dranoff G., and Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158 (1997) 2723-2730
17. Oh Y.K., and Swanson J.A. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J Cell Biol 132 (1996) 585-593
18. Tomazic-Jezic V.J., Merritt K., and Umbreit T.H. Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res 55 (2001) 523-529
19. Foged C., Brodin B., Frokjaer S., and Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298 (2005) 315-322
20. Lutsiak M.E., Robinson D.R., Coester C., Kwon G.S., and Samuel J. Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res 19 (2002) 1480-1487
21. Panyam J., and Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20 (2002) 212-220
22. Walter E., Dreher D., Kok M., Thiele L., Kiama S.G., Gehr P., et al. Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Release 76 (2001) 149-168
23. Jones B.G., Dickinson P.A., Gumbleton M., and Kellaway I.W. The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages. Int J Pharm 236 (2002) 65-79
24. Peyre M., Fleck R., Hockley D., Gander B., and Sesardic D. In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation. Vaccine 22 (2004) 2430-2437
25. Desai M.P., Labhasetwar V., Amidon G.L., and Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13 (1996) 1838-1845
26. Horisawa E., Kubota K., Tuboi I., Sato K., Yamamoto H., Takeuchi H., et al. Size-dependency of dl-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res 19 (2002) 132-139
27. Foster K.A., Yazdanian M., and Audus K.L. Microparticulate uptake mechanisms of in vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol 53 (2001) 57-66
28. Lai S.K., Hida K., Man S.T., Chen C., Machamer C., Schroer T.A., et al. Priveleged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 28 (2007) 2876-2884
29. Hirota K., Hasegawa T., Hinata H., Ito F., Inagawa H., Kochi C., et al. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages. J Control Release 119 (2007) 69-76
30. Lacasse F.X., Filion M.C., Phillips N.C., Escher E., McMullen J.N., and Hildgen P. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm Res 15 (1998) 312-317
31. Ramachandra L., Song R., and Harding C.V. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. J Immunol 162 (1999) 3263-3272
32. Raghuvanshi R.S., Katare Y.K., Lalwani K., Ali M.M., Singh O., and Panda A.K. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Int J Pharm 245 (2002) 109-121
33. Katare Y.K., Muthukumaran T., and Panda A.K. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharm 301 (2005) 149-160
34. Katare Y.K., Panda A.K., Lalwani K., Haque I.U., and Ali M.M. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine. Drug Deliv 10 (2003) 231-238
35. Hed J., Hallden G., Johansson S.G., and Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 101 (1987) 119-125
36. Muller R.H., Ruhl D., Luck M., and Paulke B.R. Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity, and plasma protein adsorption. Pharm Res 14 (1997) 18-24
37. Sahoo S.K., Panyam J., Prabha S., and Labhasetwar V. Residual polyvinyl alcohol associated with poly(d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82 (2002) 105-114
38. de Chastellier C., and Thilo L. Phagosome maturation and fusion with lysosomes in relation to surface property and size of the phagocytic particle. Eur J Cell Biol 74 (1997) 49-62
39. Conner S.D., and Schmid S.L. Regulated portals of entry into the cell. Nature 422 (2003) 37-44
40. Trombetta E.S., and Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23 (2005) 975-1028
41. Ramachandra L., and Harding C.V. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing. J Immunol 164 (2000) 5103-5112
42. Ramachandra L., Noss E., Boom W.H., and Harding C.V. Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules. Cell Microbiol 1 (1999) 205-214
43. Vidard L., Kovacsovics-Bankowski M., Kraeft S.K., Chen L.B., Benacerraf B., and Rock K.L. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J Immunol 156 (1996) 2809-2818
44. Waeckerle-Men Y., Scandella E., Uetz-Von Allmen E., Ludewig B., Gillessen S., Merkle H.P., et al. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods 287 (2004) 109-124
45. Babensee J.E., and Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 74 (2005) 503-510
46. Fischer S., Uetz-Von Allmen E., Waeckerle-Men Y., Groettrup M., Merkle H.P., and Gander B. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials 28 (2007) 994-1004
47. Waeckerle-Men Y., and Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv Drug Deliv Rev 57 (2005) 475-482
48. Sun H., Pollock K.G., and Brewer J.M. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21 (2003) 849-855